U.S. Molecular Diagnostics Market Test Volume Forecasts & Companies Analyzed in Research Report

News provided by

Oct 03, 2014, 10:00 ET

DALLAS, October 3, 2014 /PRNewswire/ --

MarketReportsOnline.com adds United States (USA) - Molecular Diagnostics Market, Test Volume Forecast & Companies, a 2014 market research report of 128 pages to its online business intelligence library. This research provides a comprehensive assessment of the fast-evolving, high-growth Global Molecular Diagnostics Market. Complete report and its comprehensive Table of Contents are available at http://www.marketreportsonline.com/327654-toc.html .

This United States molecular diagnostics market (US) report with 87 Figures studies the United States Molecular Diagnostics industry from 4 view points: Market and Forecast, Application Wise Market & Forecast, Application Wise Test Volume & Forecast and Company Wise Molecular Diagnostics Sales & Forecast. The application wise molecular diagnostics test volume market analysis and forecast covers oncology testing market (breast cancer testing, colorectal cancer testing, prostate cancer and other cancer testing markets), infectious disease testing market (virology testing, HPV, HAI and critical care testing markets), genetic testing market, blood screening market, food pathogen testing market and tissue typing (HLA) testing market information and forecasts to 2018.

United States Molecular Diagnostics Market Sales and Forecast by company covered in this research provides data and information for companies like Roche, Abbott Laboratories, Myriad Genetics, Biomerieux, Qiagen, Hologic Inc. (Acquired Gen-Probe), Becton Dickinson, Siemens, Cepheid and Others. Order a copy of this research at http://www.marketreportsonline.com/contacts/purchase.php?name=327654 .

Partial List of Figures provided in United States (USA) - Molecular Diagnostics Market, Test Volume Forecast & Companies research report covers:

Figure 2-2: United States - Forecast for Molecular Diagnostics Market (Million US$), 2014 - 2018
Figure 2-4: United States - Forecast for Molecular Diagnostics Test Volume (Million), 2014 - 2018
Figure 3-2: United States - Forecast for Molecular Diagnostics Applications Market Share (Percent), 2014 - 2018
Figure 3-4: United States - Forecast for Company Wise Molecular Diagnostics Market Share (Percent), 2014 - 2018
Figure 3-6: United States - Forecast for Molecular Diagnostics Applications Test Volume Share (Percent), 2014 - 2018
Figure 4-1: United States - Molecular Diagnostic Oncology Testing Market (Million US$), 2004 - 2013
Figure 4-2: United States - Forecast for Molecular Diagnostic Oncology Testing Market (Million US$), 2014 - 2018
Figure 4-3: United States - Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2004 - 2013
Figure 4-4: United States - Forecast for Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2014 - 2018
Figure 4-5: United States - Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2004 - 2013
Figure 4-6: United States - Forecast for Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2014 - 2018
Figure 4-7: United States - Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2004 - 2013
Figure 4-8: United States - Forecast for Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2014 - 2018
Figure 4-9: United States - Other Molecular Diagnostic Cancer Testing Market (Million US$), 2004 - 2013
Figure 4-10: United States - Forecast for Other Molecular Diagnostic Cancer Testing Market (Million US$), 2014 - 2018
Figure 4-11: United States - Infectious Disease Testing Market (Million US$), 2010 - 2013
Figure 4-12: United States - Forecast for Infectious Disease Testing Market (Million US$), 2014 - 2018
Figure 4-13: United States - Virology Testing Market (Million US$), 2007 - 2018
Figure 4-14: United States - Forecast for Virology Testing Market (Million US$), 2014 - 2018
Figure 4-16: United States - Forecast for HPV Testing Market (Million US$), 2014 - 2018
Figure 4-17: United States - HAI Testing Market (Million US$), 2010 - 2013
Figure 4-18: United States - Forecast for HAI Testing Market (Million US$), 2014 - 2018
Figure 4-20: United States - Forecast for Critical Care Testing Market (Million US$), 2014 - 2018
Figure 4-21: United States - Genetic Testing Market (Million US$), 2010 - 2013
Figure 4-22: United States - Forecast for Genetic Testing Market (Million US$), 2014 - 2018
Figure 4-23: United States - Blood Screening Market (Million US$), 2006 - 2013
Figure 4-24: United States - Forecast for Blood Screening Market (Million US$), 2014 - 2018
Figure 4-25: United States - Food Pathogen Testing Market (Million US$), 2010 - 2013
Figure 4-26: United States - Forecast for Food Pathogen Testing Market (Million US$), 2014 - 2018
Figure 4-27: United States - HLA Testing Market (Million US$), 2008 - 2013
Figure 4-28: United States - Forecast for HLA Testing Market (Million US$), 2014 - 2018
Figure 5-1: United States - Oncology Test Volume (Million), 2004 - 2013
Figure 5-2: United States - Forecast for Oncology Test Volume (Million), 2014 - 2018
Figure 5-3: United States - Breast Cancer Test Volume (Million), 2004 - 2013
Figure 5-4: United States - Forecast for Breast Cancer Test Volume (Million), 2014 - 2018
Figure 5-6: United States - Forecast for Colorectal Cancer Test Volume (Million), 2014 - 2018
Figure 5-7: United States - Prostate Cancer Test Volume (Million), 2004 - 2013
Figure 5-8: United States - Forecast for Prostate Cancer Test Volume (Million), 2014 - 2018
Figure 5-9: United States - Other Cancer Test Volume (Million), 2004 - 2013
Figure 5-10: United States - Forecast for Other Cancer Test Volume (Million), 2014 - 2018
Figure 5-12: United States - Forecast for Infectious Disease Test Volume (Million), 2014 - 2018
Figure 5-14: United States - Forecast for Virology Test Volume (Million), 2014 - 2018
Figure 5-16: United States - Forecast for HPV Test Volume (Million), 2014 - 2018
Figure 5-18: United States - Forecast for HAI Test Volume (Million), 2014 - 2018
Figure 5-20: United States - Forecast for Critical Care Test Volume (Million), 2014 - 2018
Figure 5-22: United States - Forecast for Genetic Testing Test Volume (Million), 2014 - 2018
Figure 5-24: United States - Forecast for Blood Screening Test Volume (Million), 2014 - 2018
Figure 5-26: United States - Forecast for Food Pathogen Test Volume (Million), 2014 - 2018
Figure 5-28: United States - Forecast for HLA Test Volume (Million), 2014 - 2018
Figure 6-2: Roche - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-4: Abbott Laboratories - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-6: Myriad Genetics - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-8: Biomerieux - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-12: Hologic-Gen-Probe - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-14: Becton Dickinson - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-16: Siemens - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-17: Cepheid - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
Figure 6-19: Others - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
Figure 6-20: Others - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 7-1: United States - Investment in the Human Genome Project (Billion US$), 2003, 2012

Other healthcare market reports available with MarketReportsOnline.com include:

Future Horizons and Growth Strategies in the US Home/Self Testing Market 2014 is a 175 pages research report that provides analysis of the major home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Complete report is available at http://www.marketreportsonline.com/353385.html .

Roche Partnering 2009-2014 is a 100 pages on-demand business intelligence study which can be delivered within 3-4 working days of ordering it online. The Partnering Agreements with Roche report provides an in-depth insight into the partnering interests and activities of one of the world's leading biopharma companies. This report provides all the information you require to better understand Roche and its partnering interests and activities over the past five years.
Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company's business development objectives. In addition, contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. Read more at http://www.marketreportsonline.com/165099.html .

About Us:

Market Reports Online is your one-stop online shop for syndicated industry research reports on 25+ categories and their sub-sectors. We bring to you to the latest in market research across multiple industries and geographies from leading research publishers across the globe.

Contact:

Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441
[email protected]

Connect With Us on:

Facebook: https://www.facebook.com/MarketReportsOnline

Twitter: https://twitter.com/marketreportsol

G+ / Google Plus: https://plus.google.com/108330077369677148621/posts

RSS/Feeds: http://www.marketreportsonline.com/feed/l-latestreports.xml

SOURCE Market Reports Online